Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism

BACKGROUND: Intracranial hemorrhage (ICH) is a common and often devastating outcome in patients with brain tumors. Despite this, there is little evidence to guide anticoagulation management following an initial ICH event. OBJECTIVES: To analyze the risk of recurrent hemorrhagic and thrombotic outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Carney, Brian J., Uhlmann, Erik J., Puligandla, Maneka, Mantia, Charlene, Weber, Griffin M., Neuberg, Donna S., Zwicker, Jeffrey I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354400/
https://www.ncbi.nlm.nih.gov/pubmed/32685895
http://dx.doi.org/10.1002/rth2.12377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354400/
https://www.ncbi.nlm.nih.gov/pubmed/32685895
http://dx.doi.org/10.1002/rth2.12377

Ejemplares similares